VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F22%3A00076896" target="_blank" >RIV/65269705:_____/22:00076896 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/22:00127302
Result on the web
<a href="https://reader.elsevier.com/reader/sd/pii/S0264410X22006053?token=BEDA6CA29D60615E9B94F8E91DE2136D06F0C7358B424C1CCA34BC819B7F552754DC4B2817CD4F2AE4610FA2C293F04C&originRegion=eu-west-1&originCreation=20230207105920" target="_blank" >https://reader.elsevier.com/reader/sd/pii/S0264410X22006053?token=BEDA6CA29D60615E9B94F8E91DE2136D06F0C7358B424C1CCA34BC819B7F552754DC4B2817CD4F2AE4610FA2C293F04C&originRegion=eu-west-1&originCreation=20230207105920</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.vaccine.2022.05.022" target="_blank" >10.1016/j.vaccine.2022.05.022</a>
Alternative languages
Result language
angličtina
Original language name
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
Original language description
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has evidenced the key role of vaccine design, obtention, production and administration to successfully fight against infectious diseases and to provide efficient remedies for the citizens. Although clinical trials were rapidly established during this pandemic, identifying suitable study subjects can be challenging. For this reason, the University Hospital Cologne established a volunteer registry for participation in clinical trials first in Germany, which has now been incorporated into the European VACCELERATE clinical trials network and grew to a European Volunteer Registry. As such, VACCELERATE's Volunteer Registry aims to become a common entry point for potential volunteers in future clinical trials in Europe. Methods: Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. The registry is open to both adults and children, complying with national legal consent requirements. Results: As of May 2022, the questionnaire is available in 12 countries and 14 languages. Up to date, more than 36,000 volunteers have registered, mainly from Germany. Within the first year since its establishment, the VACCELERATE Volunteer Registry has matched more than 15,000 volunteers to clinical trials. The VACCELERATE Volunteer Registry will be launched in further European countries in the coming months. Conclusions: The VACCELERATE Volunteer Registry is an active single-entry point for European residents interested in COVID-19 clinical trials participation in 12 countries (i.e., Austria, Cyprus, Germany, Greece, Ireland, Lithuania, Norway, Portugal, Spain, Sweden and Turkey). To date, more than 15,000 registered individuals have been connected to clinical trials in Germany alone. The registry is currently in the implementation phase in 5 additional countries (i.e., Belgium, Czech Republic, Hungary, Israel and the Netherlands). (C) 2022 The Authors. Published by Elsevier Ltd.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Vaccine
ISSN
0264-410X
e-ISSN
1873-2518
Volume of the periodical
40
Issue of the periodical within the volume
31
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
4090-4097
UT code for WoS article
000832911500003
EID of the result in the Scopus database
—